TPSG1

Tryptase gamma · Q9NRR2 · TPSG1 on Sugi Atlas →

12,913 patent compounds predicted against TPSG1, 5,852 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL951611 SCHEMBL951611 0.58 16/20
SCHEMBL3332397 SCHEMBL3332397 0.68 15/20
SCHEMBL3335469 SCHEMBL3335469 0.68 15/20
SCHEMBL3337061 SCHEMBL3337061 0.56 14/20
SCHEMBL3339780 SCHEMBL3339780 0.60 10/20
SCHEMBL3339769 SCHEMBL3339769 0.59 10/20
SCHEMBL3336049 SCHEMBL3336049 0.54 9/20
SCHEMBL1668497 SCHEMBL1668497 0.53 9/20
SCHEMBL3328351 SCHEMBL3328351 0.48 9/20
SCHEMBL3337050 SCHEMBL3337050 0.53 8/20
SCHEMBL3337054 SCHEMBL3337054 0.53 8/20
SCHEMBL1668863 SCHEMBL1668863 0.51 8/20
SCHEMBL389996 SCHEMBL389996 0.46 8/20
SCHEMBL1669095 SCHEMBL1669095 0.53 7/20
SCHEMBL1668474 SCHEMBL1668474 0.52 7/20
SCHEMBL329382 SCHEMBL329382 0.47 7/20
SCHEMBL2344320 SCHEMBL2344320 0.46 7/20
SCHEMBL3163506 SCHEMBL3163506 0.43 7/20
SCHEMBL1668904 SCHEMBL1668904 0.54 6/20
SCHEMBL953680 SCHEMBL953680 0.54 6/20

Clinical trials — most relevant to TPSG1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients PHASE2/PHASE3COMPLETED
Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis PHASE3COMPLETED
Effects of Anti-TSLP in Patients With Asthma PHASE2COMPLETED
The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose PHASE2COMPLETED
Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome PHASE2UNKNOWN
A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis PHASE2COMPLETED
Role of Tryptase Levels in Patients With Stable Coronary Artery Disease. nanRECRUITING
Chemokine Mechanisms in Chronic Pelvic Pain nanCOMPLETED
Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing nanCOMPLETED
Tryptase Level as a Marker of Complications in Transcatheter Aortic Valve Replacement nanUNKNOWN
Improvement of Foodallergy Diagnostic in Gastrointestinal Tract nanCOMPLETED
Investigation of the Frequency of Hereditary Hyper Alpha-tryptasemia in Patients With Elevated Basal Tryptasemia nanACTIVE_NOT_RECRUITING
In Vivo Assessment of Histamine Pharmacodynamics nanWITHDRAWN
Dosage of Serum Tryptase Levels in a Population of Premature Newborns to Evaluate Mast Cell Activity nanCOMPLETED
Cause and Natural Course of Pediatric-Onset Mastocytosis nanCOMPLETED
Assessment of Burden Disease in Patients With Mast Cell Disorders nanUNKNOWN
Effect of FODMAPs on Mucosal Inflammation in IBS Patients nanUNKNOWN
Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations nanCOMPLETED
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity nanCOMPLETED
Allergy and Immunology Natural History Study nanRECRUITING
GI Alpha-Gal Study nanCOMPLETED
Persistence of Sensitization to Contrast Media nanNOT_YET_RECRUITING
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals nanCOMPLETED
Are Mast Cells Involved in Autoinflammatory Diseases nanNOT_YET_RECRUITING
Mast Cells and Its Proteases in COPD nanUNKNOWN
Perioperative Anaphylaxis in Patients Attending University Hospitals (Egypt - UK). nanCOMPLETED
Applying Systems Immunology to the Search for Personalized Biomarkers of Clinical Efficacy nanCOMPLETED
Tryptase and Coronary Heart Disease nanCOMPLETED
Cause of Unexplained Anaphylaxis nanACTIVE_NOT_RECRUITING
Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TPSG1 binder may also engage these)

ProteinNameSimilarity
Q80WM7 0.991 Q80WM7 →
Q9QUL7 0.987 Q9QUL7 →
P83748 0.987 P83748 →
PRSS8 Prostasin 0.981 landscape →
Q9GZN4 0.981 Q9GZN4 →
Q6IE59 0.981 Q6IE59 →
Q9QYZ9 0.981 Q9QYZ9 →
Q9Y6M0 0.979 Q9Y6M0 →
Q9ESD1 0.979 Q9ESD1 →
Q5K4E3 0.978 Q5K4E3 →
Q14B24 0.978 Q14B24 →
Q5K2P8 0.977 Q5K2P8 →
Q9XSM2 0.977 Q9XSM2 →
P15944 0.977 P15944 →
Q7RTY9 0.977 Q7RTY9 →
Q6UWY2 0.977 Q6UWY2 →
A6NIE9 0.977 A6NIE9 →
Q2L4Q9 0.975 Q2L4Q9 →
TPSD1 Tryptase delta (EC 3.4.21.59) (Delta-tryptase 0.974 landscape →
O43240 0.974 O43240 →
Q9H3S3 0.973 Q9H3S3 →
Q5K2P9 0.973 Q5K2P9 →
P19236 0.972 P19236 →
Q7Z5A4 0.972 Q7Z5A4 →
Q9N2D1 0.971 Q9N2D1 →
Q571E5 0.971 Q571E5 →
Q9BQR3 0.970 Q9BQR3 →
Q6BEA2 0.970 Q6BEA2 →
Q14B25 0.969 Q14B25 →
Q9ES87 0.969 Q9ES87 →